Vicky Hsu

12 papers receiving 1k citations

Vicky Hsu's Hit Papers

FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma 2020 · 160 citations
1600+2+4Years since publication50100150

Peers

Vicky Hsu
Comparison fields: 5 of 75
  • Pharmacology 370
  • Pediatrics, Perinatology and Child Health 288
  • Oncology 236
  • Pharmaceutical Science 59
  • Hematology 73
Replace Diane D. Wang with:
Diane D. Wang United States
Satjit S. Brar United States
Alex Phipps United Kingdom
Milly E. de Jonge Netherlands
Nassim Djebli France
Kenichi Umehara Switzerland
Donald Heald United States
Manuela Grimstein United States
B Booth United States
Mohamed‐Eslam F. Mohamed United States
Vicky Hsu relative to Diane D. Wang United States Diane D. Wang's profile →
Citations per field
00.5×2×3.0×
Diane D. Wang · 1×
Citations per year

Countries citing papers authored by Vicky Hsu

Since Specialization
Citations

This map shows the geographic impact of Vicky Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky Hsu more than expected).

Fields of papers citing papers by Vicky Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky Hsu. The network helps show where Vicky Hsu may publish in the future.

Co-authors

The 25 scholars most cited alongside Vicky Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vicky Hsu Line = papers co-authored together Vicky Hsu links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 2015248
2
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
Hit paper breakdown →
2020160
3 2014129
4 2019116
5 2018104
6 201583
7 201381
8 201773
9 201645
10 201818
11 20249
12 20231

About Vicky Hsu

Vicky Hsu is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Oncology, Hematology and Reproductive Medicine, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmaceutical studies and practices (3 papers), Cancer therapeutics and mechanisms (1 paper), Acute Myeloid Leukemia Research (1 paper), Science, Research, and Medicine (1 paper), Bladder and Urothelial Cancer Treatments (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Pharmacology (370 citations), Pediatrics, Perinatology and Child Health (288 citations), Oncology (236 citations), Pharmaceutical Science (59 citations) and Hematology (73 citations). Vicky Hsu has collaborated with scholars based in United States, Sweden and Japan. Frequent co-authors include Ping Zhao, Vikram P. Sinha, Joseph A. Grillo, Shiew‐Mei Huang, Yuzhuo Pan, Kathleen M. Giacomini, Kirsten B. Goldberg, Sarah E. Dorff, Rosane Charlab and Richard Pazdur. Their work appears in journals such as Clinical Pharmacokinetics, Clinical Cancer Research, Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology and CPT Pharmacometrics & Systems Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact